Obesity, Inflammation, and Periodontal Disease

The prevalence of obesity has increased substantially over the past decades in most industrialized countries. Obesity is a systemic disease that predisposes to a variety of co-morbidities and complications that affect overall health. Cross-sectional studies suggest that obesity is also associated with oral diseases, particularly periodontal disease, and prospective studies suggest that periodontitis may be related to cardiovascular disease. The possible causal relationship between obesity and periodontitis and potential underlying biological mechanisms remain to be established; however, the adipose tissue actively secretes a variety of cytokines and hormones that are involved in inflammatory processes, pointing toward similar pathways involved in the pathophysiology of obesity, periodontitis, and related inflammatory diseases. We provide an overview of the definition and assessment of obesity and of related chronic diseases and complications that may be important in the periodontist’s office. Studies that have examined the association between obesity and periodontitis are reviewed, and adipose-tissue-derived hormones and cytokines that are involved in inflammatory processes and their relationship to periodontitis are discussed. Our aim is to raise the periodontist’s awareness when treating obese individuals.

[1]  Nimesh Mody,et al.  Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.

[2]  F. Peale,et al.  FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene family , 2000, The EMBO journal.

[3]  J. Beck,et al.  Systemic Effects of Periodontitis: Epidemiology of Periodontal Disease and Cardiovascular Disease. , 2005, Journal of periodontology.

[4]  E. Rimm,et al.  Increased physical activity decreases periodontitis risk in men , 2004, European Journal of Epidemiology.

[5]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[6]  G. Frühbeck,et al.  Do resistin and resistin-like molecules also link obesity to inflammatory diseases?. , 2001, Annals of internal medicine.

[7]  C. Streckfus,et al.  Comparison of body composition and periodontal disease using nutritional assessment techniques: Third National Health and Nutrition Examination Survey (NHANES III). , 2003, Journal of clinical periodontology.

[8]  B. Burguera,et al.  Is Leptin the Link Between Fat and Bone Mass? , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  E. Borawski,et al.  Increased physical activity reduces prevalence of periodontitis. , 2005, Journal of dentistry.

[10]  S. Verma,et al.  Resistin Promotes Endothelial Cell Activation: Further Evidence of Adipokine-Endothelial Interaction , 2003, Circulation.

[11]  S. Rössner,et al.  What is “obesity” – An analysis of referral letters to an obesity unit , 1998, International Journal of Obesity.

[12]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[13]  K. Flegal Excess deaths associated with obesity: cause and effect , 2006, International Journal of Obesity.

[14]  P. Ridker On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. , 2002, Circulation.

[15]  C. Drevon,et al.  Leptin Is Expressed in and Secreted from Primary Cultures of Human Osteoblasts and Promotes Bone Mineralization , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  Y. Ichihara,et al.  Associations of medical status and physical fitness with periodontal disease. , 1999, Journal of clinical periodontology.

[17]  A Tremblay,et al.  Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.

[18]  R. Genco,et al.  A Proposed Model Linking Inflammation to Obesity, Diabetes, and Periodontal Infections. , 2005, Journal of periodontology.

[19]  GS Hotamisligil,et al.  Molecular mechanisms of insulin resistance and the role of the adipocyte , 2000, International Journal of Obesity.

[20]  R. Oppermann,et al.  Overweight and obesity as risk indicators for periodontitis in adults. , 2005, Journal of periodontology.

[21]  Jan J. Clark,et al.  Obesity: impediment to postsurgical wound healing. , 2004, Advances in skin & wound care.

[22]  Jonathan Krakoff,et al.  Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.

[23]  R. Garcia,et al.  Associations Between Periodontal Disease and Systemic Disease: Evaluating the Strength of the Evidence. , 2005, Journal of periodontology.

[24]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[25]  H. Boeing,et al.  Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.

[26]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.

[27]  S. Yusuf,et al.  Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.

[28]  McGinnis Jm,et al.  Actual causes of death in the United States. , 1993 .

[29]  U. Smith,et al.  Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. , 2001, Biochemical and biophysical research communications.

[30]  Tatsuya Takeshita,et al.  Determination of smoking and obesity as periodontitis risks using the classification and regression tree method. , 2005, Journal of periodontology.

[31]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[32]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.

[33]  G. Karsenty,et al.  The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.

[34]  W. Elliott Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults , 2006 .

[35]  J. Greenberg Underweight, overweight, obesity, and excess deaths. , 2005, JAMA.

[36]  R. Nagai,et al.  Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. , 2004, Biochemical and biophysical research communications.

[37]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[38]  J. Kolanowski Obesity and hypertension: from pathophysiology to treatment , 1999, International Journal of Obesity.

[39]  I. Reid,et al.  Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. , 2002, The Journal of endocrinology.

[40]  F. Casanueva,et al.  Leptin, from fat to inflammation: old questions and new insights , 2005, FEBS letters.

[41]  B. Howard,et al.  Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.

[42]  S. Offenbacher Periodontal diseases: pathogenesis. , 1996, Annals of periodontology.

[43]  T. Saito,et al.  Relationship between Upper Body Obesity and Periodontitis , 2001, Journal of dental research.

[44]  M. Gail,et al.  Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial , 2005, Gynecologic oncology.

[45]  G. Hotamisligil The role of TNFalpha and TNF receptors in obesity and insulin resistance. , 1999, Journal of internal medicine.

[46]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[47]  P. Vokonas,et al.  Periodontal Disease and Cardiovascular Disease. , 1996, Journal of periodontology.

[48]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[49]  K. Flegal,et al.  Secular trends in cardiovascular disease risk factors according to body mass index in US adults. , 2005, JAMA.

[50]  A. Barthel,et al.  Molecular mechanisms of insulin resistance , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[51]  E. Borawski,et al.  Periodontitis and three health-enhancing behaviors: maintaining normal weight, engaging in recommended level of exercise, and consuming a high-quality diet. , 2005, Journal of periodontology.

[52]  S. O’Rahilly,et al.  Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. , 2001, Diabetes.

[53]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[54]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[55]  Xiao Man Yang,et al.  Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue , 2002 .

[56]  R. P. Raman Obesity and Health Risks , 2002, Journal of the American College of Nutrition.

[57]  F. Pi‐Sunyer,et al.  Obesity and type 2 diabetes. , 2003, Endocrinology and metabolism clinics of North America.

[58]  M. Thun,et al.  Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.

[59]  S Margetic,et al.  Leptin: a review of its peripheral actions and interactions , 2002, International Journal of Obesity.

[60]  M. Jensen,et al.  Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.

[61]  G. Colditz,et al.  The disease burden associated with overweight and obesity. , 1999, JAMA.

[62]  Leonard H. Epstein,et al.  Overweight, obesity, and health risk. , 2000, Archives of internal medicine.

[63]  H. Krumholz,et al.  The obesity paradox: body mass index and outcomes in patients with heart failure. , 2005, Archives of internal medicine.

[64]  R. B. Johnson,et al.  Leptin within healthy and diseased human gingiva. , 2001, Journal of periodontology.

[65]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[66]  M. Matsuda,et al.  Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin , 2005, Science.

[67]  K. Kempers,et al.  Obesity: prevalence and considerations in oral and maxillofacial surgery. , 2000, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[68]  S. Kihara,et al.  Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.

[69]  G. Bray,et al.  Obesity , 2008, Annals of Internal Medicine.

[70]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[71]  Xiao Man Yang,et al.  Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. , 2002, Molecular endocrinology.

[72]  Dana Dabelea,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[73]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[74]  D. Levy,et al.  Obesity and the risk of heart failure. , 2003, The New England journal of medicine.

[75]  K. Maeda Hepatocellular injury in a patient receiving pioglitazone. , 2001, Annals of internal medicine.

[76]  G. C. Kennedy,et al.  The role of depot fat in the hypothalamic control of food intake in the rat , 1953, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[77]  J. Friedman Leptin, leptin receptors, and the control of body weight. , 1998, Nutrition reviews.

[78]  Jing Ma,et al.  Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.

[79]  F. Nishimura,et al.  Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. , 2003, Journal of periodontology.

[80]  J. Seidell,et al.  Obesity, insulin resistance and diabetes — a worldwide epidemic , 2000, British Journal of Nutrition.

[81]  Mohammad S Al-Zahrani,et al.  Obesity and periodontal disease in young, middle-aged, and older adults. , 2003, Journal of periodontology.

[82]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[83]  P. Ridker,et al.  Do atherosclerosis and type 2 diabetes share a common inflammatory basis? , 2002, European heart journal.

[84]  V. Choo WHO reassesses appropriate body-mass index for Asian populations , 2002, The Lancet.

[85]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[86]  S. Koletsky Obese spontaneously hypertensive rats--a model for study of atherosclerosis. , 1973, Experimental and molecular pathology.

[87]  G. Fantuzzi,et al.  IL-1 beta mediates leptin induction during inflammation. , 1998, The American journal of physiology.

[88]  M. Salo,et al.  Long-term physical inactivity and oral health in Finnish adults with intellectual disability , 2002, Acta odontologica Scandinavica.

[89]  G. Fantuzzi,et al.  IL-1β mediates leptin induction during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[90]  J. Friedman Leptin, leptin receptors and the control of body weight. , 2009, European journal of medical research.

[91]  A. Wolf,et al.  The medical‐care cost burden of obesity , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[92]  N. Bissada,et al.  Influence of obesity and hypertension on the severity of periodontitis in rats. , 1977, Oral surgery, oral medicine, and oral pathology.

[93]  T. Zucker,et al.  Hereditary Obesity in the Rat Associated with High Serum Fat and Cholesterol.∗ , 1962 .

[94]  G A Colditz,et al.  Impact of overweight on the risk of developing common chronic diseases during a 10-year period. , 2001, Archives of internal medicine.

[95]  T. Thomas Leptin: a potential mediator for protective effects of fat mass on bone tissue. , 2003, Joint, bone, spine : revue du rhumatisme.

[96]  E. Frongillo,et al.  The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[97]  M. Armstrong Obesity as an intrinsic factor affecting wound healing. , 1998, Journal of wound care.

[98]  B. Loos Systemic Markers of Inflammation in Periodontitis. , 2005, Journal of periodontology.

[99]  R. Semba The role of vitamin A and related retinoids in immune function. , 2009, Nutrition reviews.

[100]  R. Genco,et al.  Periodontal disease and diabetes mellitus: a two-way relationship. , 1998, Annals of periodontology.

[101]  G. Hotamisligil The role of TNFα and TNF receptors in obesity and insulin resistance , 1999 .

[102]  U. Smith,et al.  Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects* , 2003, Journal of Biological Chemistry.

[103]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[104]  R. Henry,et al.  Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.

[105]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[106]  Walter C Willett,et al.  Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. , 2005, The American journal of clinical nutrition.

[107]  P. Pussinen,et al.  Dental Infections and Cardiovascular Diseases: A Review. , 2005, Journal of periodontology.

[108]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[109]  J. Beck,et al.  Periodontitis: a risk factor for coronary heart disease? , 1998, Annals of periodontology.

[110]  Y. Kiyohara,et al.  Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study. , 2005, Journal of periodontal research.

[111]  B. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[112]  K. Kolodner,et al.  Comparing patient and physician perception of weight status with body mass index. , 2002, The American journal of medicine.

[113]  T. Pischon,et al.  Association of plasma resistin levels with coronary heart disease in women. , 2005, Obesity research.

[114]  Obesity: under-diagnosed and under-treated in hospital outpatient departments , 2002, International Journal of Obesity.

[115]  J. Friedman,et al.  Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. , 1996, The Journal of clinical investigation.

[116]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[117]  J. Tuomilehto,et al.  Blood pressure levels in the 41 populations of the WHO MONICA Project , 1997, Journal of Human Hypertension.

[118]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[119]  Y. Shimazaki,et al.  Obesity and periodontitis. , 1998, The New England journal of medicine.

[120]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[121]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[122]  M. Lazar,et al.  A family of tissue-specific resistin-like molecules. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Obesity in Adults,et al.  Identification, Evaluation, and Treatment of Overweight and Obesity , 2021, Obesity Prevention and Treatment.

[124]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[125]  E. Rimm,et al.  Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. , 2003, Obesity research.

[126]  P. Scherer,et al.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.

[127]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.